Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency and Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07476248
What this trial is testing

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Who this might be right for
Diabetic NephropathyDyslipidemia
Assiut University 84
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Not applicableStudy completedNCT00498537
What this trial is testing

Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
US Department of Veterans Affairs 30
Not applicableStudy completedNCT04670094
What this trial is testing

Comorbidities and Risk Score in COVID-19 Patients

Who this might be right for
Covid19
University of Milano Bicocca 4,555
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Not applicableStudy completedNCT06608212
What this trial is testing

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 238,038
Not applicableStudy completedNCT05690009
What this trial is testing

Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesHypertensionChronic Heart Failure+7 more
Eurasian Association of Therapists 4,580
Not applicableStudy completedNCT05407662
What this trial is testing

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes MellitusHeart Failure
Bayer 600
Not applicableUnknownNCT02515461
What this trial is testing

Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease

Who this might be right for
Diabetic Nephropathies
Odense University Hospital 30
Not applicableUnknownNCT06555146
What this trial is testing

Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Disease, Chronic
Bispebjerg Hospital 15
Not applicableStudy completedNCT03890588
What this trial is testing

Chronic Kidney Disease Clinical Decision Support

Who this might be right for
Chronic Kidney DiseasesHypertensionDiabetes
HealthPartners Institute 6,295
Large-scale testing (Phase 3)Study completedNCT00552409
What this trial is testing

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Who this might be right for
Diabetes MellitusChronic Kidney DiseaseDiabetic Kidney Disease
University of Washington 22
Not applicableStudy completedNCT01363336
What this trial is testing

Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

Who this might be right for
Hypertension
Bayer 1,882
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Post-approval studies (Phase 4)Study completedNCT01075698
What this trial is testing

A Trial of Telmisartan Prevention of Cardiovascular Disease

Who this might be right for
Hypertension
Kumamoto University 1,228
Testing effectiveness (Phase 2)Study completedNCT03270956
What this trial is testing

Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 10
Large-scale testing (Phase 3)Study completedNCT00095056
What this trial is testing

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Type 2Chronic Renal Insufficiency
Merck Sharp & Dohme LLC 91
Post-approval studies (Phase 4)Ended earlyNCT03526536
What this trial is testing

Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD

Who this might be right for
End-Stage Renal DiseaseDiabetes Mellitus
State University of New York - Downstate Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT01053936
What this trial is testing

Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 129
Next Page